Navigation Links
Solutions for Parents Who Need Cold Remedies for Their Children

Safe products available in light of FDA's Advisory

ALBUQUERQUE, N.M., Jan. 18 /PRNewswire/ -- Yesterday the FDA issued a Public Health Advisory to parents recommending that over-the-counter (OTC) cough and cold products should not be used to treat infants and children less than 2 years of age because serious and potentially life-threatening side effects can occur from such use. According to the FDA's news release there are a wide variety of rare, serious, and adverse events reported with cough and cold products. They include convulsions, rapid heart rates, decreased levels of consciousness and death. This news leaves parents of young children wondering what options are available.

Parents do have alternatives. Heel (a manufacturer of homeopathic drugs) offers safe, effective and natural medicines for infants and children suffering from common cold and flu symptoms. Physicians may confidently recommend many Heel medicines for their young patients including Viburcol(R) pediatric oral drops for restlessness and fever; Nectadyn(TM) cough syrup (formerly sold as CoughFree) for coughs (recommended for ages 2 and up); Sinusin(TM) nasal spray (also sold as Euphorbium Sinus Relief(TM)) for nasal congestion; and Traumeel(R) Ear Drops for ear pain and inflammation.

These products act rapidly to soothe and comfort children without adverse risks. Bruce Shelton, MD, MD(h), DiHom, FBIH, noted Homeopathic Family Physician in Phoenix, Ariz., commented, "Since learning how effective homeopathics are, I give all of my pediatric patients liquid complex homeopathic preparations and I see dramatic recoveries in short amounts of time without the recurrent infections seen so commonly with traditional methods." An article that appeared in Natural Solutions magazine (January, 2008) offered options of many safe homeopathic and herbal approaches. Roy Steinbock, MD, a holistic pediatrician with a practice in Boulder, Colo. recommends Heel's Euphorbium Sinus Relief(TM) nasal spray (also sold as Sinusin(TM)) for all ages, including infants.

Viburcol(R) has been clinically researched and is comparable to acetaminophen for the symptomatic treatment of acute feverish infections in children under the age of 12(1). CoughFree, has been a staple in family medicine chests as an alternative to over-the-counter cough suppressants. Both Traumeel(R) and Euphorbium Sinus Relief(TM) have been used by practitioners and their patients alike for decades due to their effective and complete relief. These products are available through health care practitioners, pharmacies and health food stores.

Heel Inc. is the U.S. subsidiary of Heel GmbH, which is one of the world's largest homeopathic pharmaceutical manufacturers with distribution in over 60 countries. For more information on other Heel products and their efficacy please visit

(1.) Muller-Krampe B et al. Symptomatic treatment of acute feverish

infections with a modern homeopathic medication. Biological Medicine

2002; Vol.31.No.2: 79-85.

SOURCE Heel Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Ken Sperling to Lead CIGNA HealthCare Retiree Solutions Unit
2. Frances Decker Named Mid-Atlantic Region Sales Executive for AllOne Health Management Solutions
3. Mirixa Debuts New Clinical Technology Solutions for Enhancing Patient Care
4. SXC Health Solutions to present at the 2007 UBS Global Life Sciences Conference
5. The Village Company Unveils Natural Bath and Body Solutions for Everyday Ailments
6. RESolutions Rapid Enrollment Solutions, LLC Mobilizes Team of Regional Recruitment Specialists(TM)
7. MedQuist and MedAssets Sign Multi-Year Contract for Clinical Documentation Workflow Solutions
8. Ingenious Med Forms Multiple Billing Company Partnerships to Market Inpatient Practice Management Solutions
9. Siemens Medical Solutions Diagnostics Announces the Release of the Rapidlab 1200 Series Version 2.0 Software
10. SYMX Builds on Top of New Microsoft Technologies to Offer Hospitals Real-Time Business and Patient Safety Solutions Using RFID Data
11. InfoLogix Signs Largest International Deal to Date with Healthcare Solutions Agreement in United Arab Emirates
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... ... convenient way to dispense prescription medications at home, so he invented the patent-pending ... monitor and dispense prescription medications. In doing so, it could help to prevent ...
(Date:11/27/2015)... ... 2015 , ... MPWH, the No.1 Herpes-only dating community in the world, revealed that over 50% ... More than 3.7 billion people under the age of 50 – or 67% of the ... first global estimates of HSV-1 infection . , "The data shocks us highly!" said ...
(Date:11/27/2015)... ... November 27, 2015 , ... Keeping in mind challenges ... health and wellness consultation, has collaborated with a leading web-based marketplace for extra-curricular ... experienced by parents and bring advice from parenting experts within their reach. As ...
(Date:11/27/2015)... ... November 27, 2015 , ... Indosoft ... announces the incorporation of Asterisk 11 LTS (Long Term Support) into its Q-Suite ... LTS brings Q-Suite 5.10 up-to-date with a version of Asterisk that will receive ...
(Date:11/26/2015)... ... 2015 , ... The Catalent Applied Drug Delivery Institute today ... dose form selection in early phase drug development. The first of these is ... together the UK’s emerging life sciences companies, corporate partners, and investors, at Milton ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , November 26, 2015 ... "Self Administration of High Viscosity Drugs" ... ) has announced the addition of the ... to their offering. --> Research and ... of the "Self Administration of High Viscosity ...
(Date:11/26/2015)... , November 26, 2015 /PRNewswire/ ... announced the addition of the  "2016 ... the European Cell Surface Marker Testing ... Opportunities"  report to their offering.  ... the addition of the  "2016 Future ...
(Date:11/25/2015)... 25, 2015  Amgen (NASDAQ: AMGN ) today ... with the United States (U.S.) ... biosimilar candidate to Humira ® (adalimumab). Amgen believes ... to the FDA and represents Amgen,s first BLA submission ... Harper , M.D., executive vice president of Research and ...
Breaking Medicine Technology: